faculty of physical therapy Cairo university
Dokki, Giza Governorate, Egypt
Location status: Recruiting
Location contact
Ali Ismail, lecturer
CONTACT
Ali MA Ismail, Lecturer
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06757829
pulmonary complications are common in sickle cell disease patients. Respiratory training using inspiratory muscle trainer (IMT) is usually a good choice to improve these complications. Recently, acupuncture like transcutaneous electrical nerve stimulation (AC-tens) may also improve these complications.
Interested in participating?
Request Info20 year–50 year
All sexes
Interventional
Not applicable
Dokki, Giza Governorate, Egypt
Location status: Recruiting
Ali Ismail, lecturer
CONTACT
Ali MA Ismail, Lecturer
PRINCIPAL_INVESTIGATOR
sickle cell disease patients whose number will be forty patients will be divided to group I who will trained with IMT (threshold inspiratory muscle training) and treated with AC-tens (the number of patients will be 20) or group II who will trained with IMT (the number of patients will be 20) . The number of sessions per week will be three sessions for IMT or AC-tens for 12 weeks. the IMT will be performed for six sets of respiratory training cycles and the set will contain 10 respiratory cycles. Also the session of AC-tens will be 45 minute on bilateral Ex-B1 acupoint. the parameters of AC-tens will be four hertz and 200 microsecond pulse duration.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
sickle cell disease patients whose number will be 20 patients will be trained with IMT (threshold inspiratory muscle training) and treated with AC-tens. The number of sessions per week will be three sessions for IMT or AC-tens for 12 weeks. the IMT will be performed for six sets of respiratory training cycles and the set will contain 10 respiratory cycles. Also the session of AC-tens will be 45 minute on bilateral Ex-B1 acupoint. the parameters of AC-tens will be four hertz and 200 microsecond pulse duration.
sickle cell disease patients whose number will be 20 patients who will trained with IMT (threshold inspiratory muscle training). The number of sessions per week will be three sessions for IMT for 12 weeks. the IMT will be performed for six sets of respiratory training cycles and the set will contain 10 respiratory cycles.
Time frame: it will be assessed after12 weeks
will be measured by spirometry
Time frame: it will be assessed after12 weeks
will be measured by spirometry
Time frame: it will be assessed after12 weeks
will be measured by spirometry
Time frame: it will be assessed after12 weeks
it will be a measure of physical capacity
Time frame: it will be assessed after12 weeks
it is a questionnaire measure of quality of life
Time frame: it will be assessed after12 weeks
it is a questionnaire measure of quality of life
Time frame: it will be measured after 12 weeks
it will be assessed by ultrasonography
Time frame: it will be measured after 12 weeks
it will be assessed by ultrasonography
Contact information is provided by the study sponsor or research team.
Ali Isamil, Lecturer
CONTACT
ali ismail, Lecturer
CONTACT
Cairo University
Other
Pulmonary Functions in Sickle Cell Disease: Response of Adding Acu-TENS to Inspiratory Muscle Training
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07187973
Anemia, Anemia, Hemolytic
Birmingham, Alabama, United States
View Trial DetailsNCT00542230
Anemia, Anemia, Hemolytic
Bethesda, Maryland, United States
View Trial DetailsNCT03937817
Alpha and Beta Thalassemia, Anemia
Bethesda, Maryland, United States
View Trial DetailsNCT02675959
Anemia, Anemia, Hemolytic
Los Angeles, California, United States
View Trial Details